{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T01:32:04Z","timestamp":1793237524062,"version":"4.5.0"},"reference-count":37,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"7","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,7]]},"abstract":"<jats:p>\n                    Xanthogranuloma is the most common category of histiocytic neoplasia, with a range of clinical behaviors from solitary cutaneous lesions to multiple cutaneous lesions and less frequent cases with evolution to disseminated disease. Solitary lesions make up 78% to 81% of total cases. We encountered 2 consecutive index patients with solitary cutaneous xanthogranuloma with NTRK overexpression by immunostaining and confirmed the presence of an\n                    <jats:italic toggle=\"yes\">NTRK1<\/jats:italic>\n                    fusion with both RNA and DNA sequencing. We screened 55 additional patients by pan-TRK immunostain, and found that 26 of 48 (54%) with solitary xanthogranulomas had TRK overexpression, whereas 0 of 7 (0%) multifocal or disseminated xanthogranulomas had TRK overexpression. We sequenced a subset of 23 patients with solitary xanthogranuloma. In all 16 patients with a positive pan-TRK immunostain, we confirmed the presence of an\n                    <jats:italic toggle=\"yes\">NTRK1<\/jats:italic>\n                    fusion using RNA and DNA sequencing. In all 7 patients that were negative by immunostain we identified no\n                    <jats:italic toggle=\"yes\">NTRK<\/jats:italic>\n                    fusion by sequencing. All patients with a fusion identified by sequencing had overexpression of the\n                    <jats:italic toggle=\"yes\">NTRK1<\/jats:italic>\n                    RNA transcript relative to wild-type tumors with a mean 58-fold increase over wild-type tumors (\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    =8.77e-15). Further, all cases with fusions had a loss of the extracellular portion of\n                    <jats:italic toggle=\"yes\">NTRK1<\/jats:italic>\n                    , and fusion partners were limited to\n                    <jats:italic toggle=\"yes\">TPM3, PRDX1, IRF2BP2, LRRIP1<\/jats:italic>\n                    , and\n                    <jats:italic toggle=\"yes\">SQSTM1<\/jats:italic>\n                    . DNA sequencing identified additional\n                    <jats:italic toggle=\"yes\">recurrent<\/jats:italic>\n                    loss of function mutations in DNA methylation genes\n                    <jats:italic toggle=\"yes\">DNMT3A, KDM5D<\/jats:italic>\n                    , and SETD2, as well as the\n                    <jats:italic toggle=\"yes\">MTOR-PI3K<\/jats:italic>\n                    pathway gene\n                    <jats:italic toggle=\"yes\">FLCN<\/jats:italic>\n                    . Recurrent copy number gains were detected in\n                    <jats:italic toggle=\"yes\">MTOR-PI3K<\/jats:italic>\n                    pathway genes\n                    <jats:italic toggle=\"yes\">PIK3CG<\/jats:italic>\n                    ,\n                    <jats:italic toggle=\"yes\">IL10Ra<\/jats:italic>\n                    , as well as transcriptional regulator\n                    <jats:italic toggle=\"yes\">PAX8<\/jats:italic>\n                    . The frequency of\n                    <jats:italic toggle=\"yes\">NTRK1<\/jats:italic>\n                    fusions appears markedly higher in solitary compared with multifocal and disseminated xanthogranuloma (54% vs. 0%). The reduced proportion of\n                    <jats:italic toggle=\"yes\">NTRK1<\/jats:italic>\n                    fusions in disseminated cases relative to solitary cases suggests that\n                    <jats:italic toggle=\"yes\">NTRK1<\/jats:italic>\n                    fusions are less efficient than MAP kinase pathway point mutations at driving tumor evolution towards disseminated disease. As\n                    <jats:italic toggle=\"yes\">NTRK1<\/jats:italic>\n                    fusions are uncommon in other histiocytoses, pan-TRK immunostain may have utility to confirm the diagnosis of xanthogranuloma in a histiocytic lineage tumor and to screen for low-risk xanthogranuloma.\n                  <\/jats:p>","DOI":"10.1097\/pas.0000000000002394","type":"journal-article","created":{"date-parts":[[2025,3,31]],"date-time":"2025-03-31T08:47:41Z","timestamp":1743410861000},"page":"639-645","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":9,"title":["NTRK Fusions in Xanthogranuloma, a Clinicopathologic and Molecular Analysis of 23 Cases"],"prefix":"10.1097","volume":"49","author":[{"given":"Brandon","family":"Umphress","sequence":"first","affiliation":[{"name":"Department of Pathology and Laboratory Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aofei","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Pathology and Laboratory Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew","family":"Kuhar","sequence":"additional","affiliation":[{"name":"Department of Pathology and Laboratory Medicine"},{"name":"Department of Dermatology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel","family":"Kowal","sequence":"additional","affiliation":[{"name":"Department of Pathology and Laboratory Medicine"},{"name":"Department of Dermatology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed K.","family":"Alomari","sequence":"additional","affiliation":[{"name":"Department of Pathology and Laboratory Medicine"},{"name":"Department of Dermatology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"LeeAnn","family":"Baldridge","sequence":"additional","affiliation":[{"name":"Department of Pathology and Laboratory Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony J.","family":"Ross","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Indiana University School of Medicine, Indianapolis, IN"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4802-2770","authenticated-orcid":false,"given":"Simon J.","family":"Warren","sequence":"additional","affiliation":[{"name":"Department of Pathology, University of Michigan School of Medicine, Ann Arbor, MI"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2025,3,31]]},"reference":[{"key":"R1-20250618","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1111\/his.15127","article-title":"Demographics and additional haematologic cancers of patients with histiocytic\/dendritic cell neoplasms","volume":"84","author":"Kemps","year":"2024","journal-title":"Histopathology"},{"key":"R2-20250618","doi-asserted-by":"crossref","first-page":"2672","DOI":"10.1182\/blood-2016-01-690636","article-title":"Revised classification of histiocytoses and neoplasms of the macrophage-dendritic cell lineages","volume":"127","author":"Emile","year":"2016","journal-title":"Blood"},{"key":"R3-20250618","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1002\/pbc.20725","article-title":"Fetal and neonatal histiocytoses","volume":"47","author":"Isaacs","year":"2006","journal-title":"Pediatr Blood Cancer"},{"key":"R4-20250618","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1097\/01.pas.0000147395.01229.06","article-title":"Juvenile xanthogranuloma in childhood and adolescence: a clinicopathologic study of 129 patients from the Kiel pediatric tumor registry","volume":"29","author":"Janssen","year":"2005","journal-title":"Am J Surg Pathol"},{"key":"R5-20250618","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1111\/cup.14355","article-title":"An NTRK-1-associated soft tissue tumor showing distinctive nodules with peripheral accentuation of cellularity","volume":"50","author":"Czaja","year":"2023","journal-title":"J Cutan Pathol"},{"key":"R6-20250618","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1038\/s41379-019-0324-7","article-title":"NTRK fusion detection across multiple assays and 33,997 cases: diagnostic implications and pitfalls","volume":"33","author":"Solomon","year":"2020","journal-title":"Mod Pathol"},{"key":"R7-20250618","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1158\/1078-0432.CCR-19-3165","article-title":"TRK Fusions are enriched in cancers with uncommon histologies and the absence of canonical driver mutations","volume":"26","author":"Rosen","year":"2020","journal-title":"Clin Cancer Res"},{"key":"R8-20250618","doi-asserted-by":"crossref","first-page":"1758835920975613","DOI":"10.1177\/1758835920975613","article-title":"A systematic review and meta-analysis of neurotrophic tyrosine receptor kinase gene fusion frequencies in solid tumors","volume":"12","author":"Forsythe","year":"2020","journal-title":"Ther Adv Med Oncol"},{"key":"R9-20250618","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1038\/s41379-021-00913-8","article-title":"NTRK insights: best practices for pathologists","volume":"35","author":"Hechtman","year":"2022","journal-title":"Mod Pathol"},{"key":"R10-20250618","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1097\/PAS.0000000000000911","article-title":"Pan-Trk immunohistochemistry is an efficient and reliable screen for the detection of NTRK fusions","volume":"41","author":"Hechtman","year":"2017","journal-title":"Am J Surg Pathol"},{"key":"R11-20250618","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1038\/s41571-018-0113-0","article-title":"NTRK fusion-positive cancers and TRK inhibitor therapy","author":"Cocco","year":"2018","journal-title":"Nat Rev Clin Oncol"},{"key":"R12-20250618","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1158\/2159-8290.CD-15-0913","article-title":"Diverse and targetable kinase alterations drive histiocytic neoplasms","volume":"6","author":"Diamond","year":"2016","journal-title":"Cancer Discov"},{"key":"R13-20250618","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1016\/j.jdcr.2020.05.032","article-title":"Disseminated non-Langerhans-cell histiocytosis with an IRF2BP2-NTRK1 gene fusion identified by next-generation sequencing","volume":"6","author":"Chan","year":"2020","journal-title":"JAAD Case Rep"},{"key":"R14-20250618","first-page":"13030\/qt07d3f2xk","article-title":"Generalized eruptive histiocytosis associated with a novel fusion in LMNA-NTRK1","volume":"22","author":"Pinney","year":"2016","journal-title":"Dermatol Online J"},{"key":"R15-20250618","first-page":"1231","article-title":"Adult xanthogranuloma with LMNA-NTRK1 gene fusion - a possible driver of proliferation","volume":"20","author":"Ak","year":"2022","journal-title":"J Dtsch Dermatol Ges"},{"key":"R16-20250618","doi-asserted-by":"crossref","first-page":"1839","DOI":"10.1038\/s41591-019-0653-6","article-title":"Activating mutations in CSF1R and additional receptor tyrosine kinases in histiocytic neoplasms","volume":"25","author":"Durham","year":"2019","journal-title":"Nat Med"},{"key":"R17-20250618","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1111\/cup.14510","article-title":"NTRK expression is common in xanthogranuloma and is associated with the solitary variant","volume":"50","author":"Umphress","year":"2023","journal-title":"J Cutan Pathol"},{"issue":"suppl_8","key":"R18-20250618","doi-asserted-by":"crossref","first-page":"viii16","DOI":"10.1093\/annonc\/mdz384","article-title":"Identifying patients with NTRK fusion cancer","volume":"30","author":"Solomon","year":"2019","journal-title":"Ann Oncol"},{"key":"R19-20250618","doi-asserted-by":"crossref","first-page":"25826","DOI":"10.18632\/oncotarget.25381","article-title":"Clinical validation of the tempus xO assay","volume":"9","author":"Beaubier","year":"2018","journal-title":"Oncotarget"},{"key":"R20-20250618","doi-asserted-by":"crossref","first-page":"2384","DOI":"10.18632\/oncotarget.26797","article-title":"Clinical validation of the Tempus xT next-generation targeted oncology sequencing assay","volume":"10","author":"Beaubier","year":"2019","journal-title":"Oncotarget"},{"key":"R21-20250618","doi-asserted-by":"crossref","first-page":"e1004873","DOI":"10.1371\/journal.pcbi.1004873","article-title":"CNVkit: genome-wide copy number detection and visualization from targeted DNA sequencing","volume":"12","author":"Talevich","year":"2016","journal-title":"PLoS Comput Biol"},{"key":"R22-20250618","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/j.jmoldx.2019.03.008","article-title":"Detection of tumor NTRK gene fusions to identify patients who may benefit from tyrosine kinase (TRK) inhibitor therapy","volume":"21","author":"Hsiao","year":"2019","journal-title":"J Mol Diagn"},{"key":"R23-20250618","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.cancergen.2023.08.004","article-title":"Acute myeloid leukemia with LRRFIP1::FGFR1 rearrangement and a complex karyotype","volume":"278-279","author":"Qian","year":"2023","journal-title":"Cancer Genet"},{"key":"R24-20250618","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1111\/cup.13521","article-title":"The role of gene fusions in melanocytic neoplasms","volume":"46","author":"Quan","year":"2019","journal-title":"J Cutan Pathol"},{"key":"R25-20250618","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1007\/s10637-020-00984-5","article-title":"A novel LRRFIP1-ALK fusion in inflammatory myofibroblastic tumor of hip and response to crizotinib","volume":"39","author":"Liu","year":"2021","journal-title":"Invest New Drugs"},{"key":"R26-20250618","doi-asserted-by":"crossref","first-page":"2651","DOI":"10.1158\/1078-0432.CCR-21-3521","article-title":"ALK amplification and rearrangements are recurrent targetable events in congenital and adult glioblastoma","volume":"29","author":"Blandin","year":"2023","journal-title":"Clin Cancer Res"},{"key":"R27-20250618","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1086\/430842","article-title":"Germline BHD-mutation spectrum and phenotype analysis of a large cohort of families with Birt-Hogg-Dub\u00e9 syndrome","volume":"76","author":"Schmidt","year":"2005","journal-title":"Am J Hum Genet"},{"key":"R28-20250618","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1002\/stem.2293","article-title":"Loss of folliculin disrupts hematopoietic stem cell quiescence and homeostasis resulting in bone marrow failure","volume":"34","author":"Baba","year":"2016","journal-title":"Stem Cells"},{"key":"R29-20250618","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1161\/ATVBAHA.123.320183","article-title":"Nonpreferential but detrimental accumulation of macrophages with clonal hematopoiesis-driver mutations in cardiovascular tissues-brief report","volume":"44","author":"Dederichs","year":"2024","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"R30-20250618","doi-asserted-by":"crossref","first-page":"145","DOI":"10.3343\/alm.2023.43.2.145","article-title":"Clinical, mutational, and transcriptomic characteristics in elderly Korean individuals with clonal hematopoiesis driver mutations","volume":"43","author":"Moon","year":"2023","journal-title":"Ann Lab Med"},{"key":"R31-20250618","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1111\/bjh.18811","article-title":"New insights into the clinical characteristics of SETD2-mutated acute myeloid leukaemia","volume":"202","author":"Zhang","year":"2023","journal-title":"Br J Haematol"},{"key":"R32-20250618","doi-asserted-by":"crossref","first-page":"114814","DOI":"10.1016\/j.bcp.2021.114814","article-title":"KDM5D inhibits the transcriptional activation of FKBP4 by suppressing the expression of E2F1 in colorectal cancer in males","volume":"194","author":"Liu","year":"2021","journal-title":"Biochem Pharmacol"},{"key":"R33-20250618","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1038\/s41417-023-00589-z","article-title":"Amplified therapeutic targets in high-grade serous ovarian carcinoma - a review of the literature with quantitative appraisal","volume":"30","author":"Talbot","year":"2023","journal-title":"Cancer Gene Ther"},{"key":"R34-20250618","doi-asserted-by":"crossref","first-page":"4824","DOI":"10.1038\/onc.2011.190","article-title":"PAX8 promotes tumor cell growth by transcriptionally regulating E2F1 and stabilizing RB protein","volume":"30","author":"Li","year":"2011","journal-title":"Oncogene"},{"key":"R35-20250618","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1186\/s12885-021-07826-4","article-title":"Diverse mechanisms activate the PI 3-kinase\/mTOR pathway in melanomas: implications for the use of PI 3-kinase inhibitors to overcome resistance to inhibitors of BRAF and MEK","volume":"21","author":"Tran","year":"2021","journal-title":"BMC Cancer"},{"key":"R36-20250618","doi-asserted-by":"crossref","first-page":"4436","DOI":"10.4049\/jimmunol.167.8.4436","article-title":"IL-10 inhibits apoptosis of promyeloid cells by activating insulin receptor substrate-2 and phosphatidylinositol 3\u2019-kinase","volume":"167","author":"Zhou","year":"2001","journal-title":"J Immunol"},{"key":"R37-20250618","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1038\/s41389-023-00454-6","article-title":"Generating in vitro models of NTRK-fusion mesenchymal neoplasia as tools for investigating kinase oncogenic activation and response to targeted therapy","volume":"12","author":"Vanoli","year":"2023","journal-title":"Oncogenesis"}],"container-title":["American Journal of Surgical Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/PAS.0000000000002394","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,18]],"date-time":"2025-06-18T17:00:12Z","timestamp":1750266012000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/PAS.0000000000002394"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,31]]},"references-count":37,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/pas.0000000000002394","relation":{},"ISSN":["0147-5185","1532-0979"],"issn-type":[{"value":"0147-5185","type":"print"},{"value":"1532-0979","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,31]]}}}